Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Orthofix MedicalOFIX -2.20%57 Days Sales Outstanding is 59.18 as of Jun. 2026, which is 1% below its 10-year median of 59.66. GuruFocus rates OFIX with a GF Score™ of 57/100 and a GF Value™ of $13.93 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Orthofix Medical ranks better than 58.4% on this metric.
The historical rank and industry rank for Orthofix Medical's Days Sales Outstanding or its related term are showing as below:
OFIX'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.02 Med: 59.66 Max: 71.48
Current: 58.68
During the past 13 years, Orthofix Medical's highest Days Sales Outstanding was 71.48. The lowest was 51.02. And the median was 59.66.
OFIX's Days Sales Outstanding is ranked better than 58.4% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.455
vs OFIX: 58.68
Orthofix Medical's Days Sales Outstanding
increased
from Jun. 2025 (58.72) to Jun. 2026 (59.18).
Orthofix Medical (NAS:OFIX) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Orthofix Medical Days Sales Outstanding Related Terms
Orthofix Medical Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Orthofix Medical's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OFIX vs VMD, VREX, KIDS: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Orthofix Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orthofix Medical Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Orthofix Medical's Days Sales Outstanding falls into.
Orthofix Medical Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orthofix Medical (OFIX) has a Days Sales Outstanding of 59.18 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Orthofix Medical and its competitors. This is near median its historical median of 59.66. Over the past decade, Orthofix Medical's Days Sales Outstanding has ranged from 51.02 to 71.48. According to the industry distribution chart, Orthofix Medical ranks #337 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 41.6%.
Is Orthofix Medical's Days Sales Outstanding too high?
Orthofix Medical's current Days Sales Outstanding of 59.18 is near median its 10-year median of 59.66. Over the past 10 years, this metric has ranged from a low of 51.02 to a high of 71.48. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.46. Orthofix Medical's value of 59.18 is 9.6% below this industry median. Based on the distribution chart, Orthofix Medical ranks #337 out of 810 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Orthofix Medical has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Orthofix Medical's Days Sales Outstanding compare to VMD and VREX?
According to the Medical Devices & Instruments industry distribution chart, Orthofix Medical ranks #337 out of 810 companies for Days Sales Outstanding. This puts Orthofix Medical in the upper half of its industry. The industry median Days Sales Outstanding is 65.46. Orthofix Medical's value of 59.18 is 9.6% below this benchmark. Historically, Orthofix Medical's own Days Sales Outstanding has ranged from 51.02 to 71.48 over the past decade. While the company's 10-year median is 59.66 vs. the industry median of 65.46, Orthofix Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.46, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orthofix Medical's current Days Sales Outstanding of 59.18 is 9.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Orthofix Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orthofix Medical's current Days Sales Outstanding is 59.18, which is near median its own 10-year median of 59.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orthofix Medical stock overvalued right now?
Based on GuruFocus' analysis, Orthofix Medical (OFIX) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.93, compared to a current price of $9.79 — trading 29.7% below its estimated fair value. The current Days Sales Outstanding is 59.18, which is near median its 10-year median of 59.66 and 9.6% below the Medical Devices & Instruments industry median of 65.46. Orthofix Medical's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Orthofix Medical (OFIX), the current Days Sales Outstanding is 59.18 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orthofix Medical (OFIX) Overvalued in 2026?
Based on GuruFocus' analysis, Orthofix Medical stock appears to be undervalued.
The current stock price of $9.79 is trading 29.7% below its estimated GF Value™ of $13.93.
GuruFocus considers Orthofix Medical to be Modestly Undervalued.
Key valuation signals for OFIX:
Days Sales Outstanding: 59.18 (near median its 10-year median of 59.66)
GF Value™: $13.93 vs. price of $9.79 (29.7% below fair value)
Industry Position: 9.6% below the Medical Devices & Instruments median (#337 of 810)
No single metric tells the full story. See the OFIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
57GF Score
Get the complete analysis for OFIX
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OFIX has been successfully added to your 
